PESUA23 Longer intervals between SARS-CoV-2 infection and SpikeVax doses improve the neutralization of different variants of concernPoster exhibitionImmune responses to SARS-Cov2
EPC210 Long-acting injectable HIV pre-exposure prophylaxis interest among people who inject drugs in the San Diego-Tijuana border regionE-posterScale up of PrEP
EPB182 Long-acting cabotegravir+rilpivirine injection site reactions: pooled Week 96 resultsE-posterLong-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches)
EPB180 Long-acting cabotegravir+rilpivirine in older adults: pooled Phase 3 Week 96E-posterLong-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches)
PESAE07 Long term effects of donor transition processes and their potential influence on the realization of the country's 90-90-90 targets. Experiences from a subnational level in UgandaPoster exhibitionImplementation science of scaling up HIV treatment
OALBX0107 Long acting cabotegravir: updated efficacy and safety results from HPTN 084Oral abstract session with live Q&AOther new HIV prevention tools
EPD523 Loneliness and sexual risk-taking among gay, bisexual and other men who have sex with men in the context of HIV and COVID-19, two ongoing pandemicsE-posterSocial and behavioural aspects and approaches to COVID-19
EPD314 Loneliness and its correlates in older people living with HIV in Wuxi, China: a cross-sectional studyE-posterOther behavioural approaches
OAD0704 Loneliness and ARV adherence: results from a cohort study of people living with HIV in Ontario, CanadaOral abstract session with live Q&AConceptualizing social and structural factors and their impacts
EPD076 Location-based dating platform intervention (LBDPi) is an effective model in reaching high-risk MSME-posterGay men other men who have sex with men
1081 - 1090 of 2485 items